End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.52 EUR | +1.31% |
|
-3.42% | +0.05% |
06-26 | Chemical industry wage partners seek solution before the end of the peace period | DP |
06-24 | EVONIK : Buy rating from Baader Bank | ZD |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company sustains low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.05% | 9.53B | - | ||
+21.33% | 68.87B | A- | ||
-5.01% | 46.12B | A- | ||
+24.57% | 44.85B | B+ | ||
+30.93% | 27.9B | A- | ||
+8.44% | 19.38B | C+ | ||
+16.07% | 17.2B | B+ | ||
-10.88% | 14.68B | B+ | ||
-29.11% | 14.14B | A- | ||
+20.62% | 11.33B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EVK Stock
- EVK Stock
- Ratings Evonik Industries AG